Received Apr 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 4 | B0005 | IM / LA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | LG5574 | IM / LA |
No adverse event reported. Reporting per Moderna after a temperature excursion, vaccine remained viable after the excursion per Moderna.
None reported
opioid use disorder, sedative dependence, alcohol use disorder, chronic schizophrenia, nicotine dependence, PTSD, SARS CoV-2
quetiapine, naloxone, fluticasone
No known allergies
N/A